111 related articles for article (PubMed ID: 21761228)
1. Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
Kawaji H; Ishii M; Tamaki Y; Hamasaki M; Ishikawa H; Sasaki K; Dairaku K; Takagi M
Mod Rheumatol; 2012 Apr; 22(2):216-22. PubMed ID: 21761228
[TBL] [Abstract][Full Text] [Related]
2. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Yamaguchi T; Hasegawa M; Niimi R; Sudo A
Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
[TBL] [Abstract][Full Text] [Related]
3. The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer.
Niimi R; Hasegawa M; Shi DQ; Sudo A
Thromb Res; 2012 Nov; 130(5):759-64. PubMed ID: 22192153
[TBL] [Abstract][Full Text] [Related]
4. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
5. [Effect of bone cement application on the incidence of deep vein thrombosis in major joint arthroplasties].
Aslan A; Ağar E; Aydoğan NH; Atay T; Baydar ML; Kırdemir V; Ozden A
Eklem Hastalik Cerrahisi; 2011 Dec; 22(3):149-54. PubMed ID: 22085350
[TBL] [Abstract][Full Text] [Related]
6. The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study.
Cohen AT; Skinner JA; Warwick D; Brenkel I
J Bone Joint Surg Br; 2007 Jul; 89(7):887-92. PubMed ID: 17673580
[TBL] [Abstract][Full Text] [Related]
7. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
Ishibe M; Kariya S
Hip Int; 2011; 21(6):684-7. PubMed ID: 22101618
[TBL] [Abstract][Full Text] [Related]
8. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR;
Lancet; 2002 May; 359(9319):1721-6. PubMed ID: 12049860
[TBL] [Abstract][Full Text] [Related]
9. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lassen MR; Bauer KA; Eriksson BI; Turpie AG;
Lancet; 2002 May; 359(9319):1715-20. PubMed ID: 12049858
[TBL] [Abstract][Full Text] [Related]
10. Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgery.
Tsuda K; Nishii T; Sakai T; Takao M; Nakamura N; Sugano N
J Thromb Thrombolysis; 2016 Apr; 41(3):413-21. PubMed ID: 26184606
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Turpie AG
Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
Keeney JA; Clohisy JC; Curry MC; Maloney WJ
J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery.
Sasaki S; Miyakoshi N; Matsuura H; Saitoh H; Kudoh D; Shimada Y
J Orthop Sci; 2009 Sep; 14(5):491-6. PubMed ID: 19802659
[TBL] [Abstract][Full Text] [Related]
17. [Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty].
Enokiya T; Muraki Y; Iwamoto T; Kawase R; Hasegawa M; Sudo A; Uchida A; Okuda M
Yakugaku Zasshi; 2012; 132(5):683-7. PubMed ID: 22687701
[TBL] [Abstract][Full Text] [Related]
18. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Turpie AG; Eriksson BI; Bauer KA; Lassen MR
Chest; 2003 Dec; 124(6 Suppl):371S-378S. PubMed ID: 14668420
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
[TBL] [Abstract][Full Text] [Related]
20. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]